Innovent Biologics (PK)【IVBXF】銘柄情報

Innovent Biologics Inc (PK) (IVBXF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

11.392

( 0.41% )

買値

9.86

売値

11.96

出来高

1,162

平均取引量 (3 か月)

US$ 13,776,887

財務取引量

US$ 13,238

11.392 日の範囲 11.392

9.10 52 週間の範囲 15.12

時価総額

19.802B

企業価値

120.87B

前日終値

11.346

始値

11.392

時刻

109

10.9

(seller)

最終取引時間

VWAP

11.392

歳入

13.04B

純利益

813.57M

発行済株式数

1,738,237,233

浮動株比率 (%)

92.91%

機関投資家保有比率 (%)

47.77%

配当利回り

PER

166.82

株価売上高倍率 (PSR)

10.45

1 株当たり利益 (EPS)

0.47

ベータ

0.2

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal ant... Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People’s Republic of China. 詳細を表示

セクター

業界

ウェブサイト

www.innoventbio.com

本社

Suzhou, China

設立

2026

Innovent Biologics Inc (PK) is listed in the sector of the その他OTC with ticker IVBXF. The last closing price for Innovent Biologics (PK) was US$11.35. Over the last year, Innovent Biologics (PK) shares have traded in a share price range of US$ 9.10 to US$ 15.12.

Innovent Biologics (PK) currently has 1,738,237,233 shares in issue. The market capitalisation of Innovent Biologics (PK) is US$19.80 billion. Innovent Biologics (PK) has a price to earnings ratio (PE ratio) of 166.82.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.002	-0.0175530981218	11.394	11.676	10.152	1632	11.23909161	CS
4	1.892	19.9157894737	9.5	11.676	9.13	1588	10.17933764	CS
12	0.2812	2.53087086438	11.1108	12.35	9.1	7897	11.02227531	CS
26	0.242	2.17040358744	11.15	12.35	9.1	4841	10.97765242	CS
52	-0.078	-0.680034873583	11.47	15.12	9.1	18919	12.25082687	CS
156	7.412	186.231155779	3.98	15.12	3.55	64617	6.29780482	CS
260	0.842845	7.98969206538	10.549155	15.12	2.29	49085	6.37664872	CS